Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Liver Transpl. 2019 Sep 19;25(12):1747–1755. doi: 10.1002/lt.25630

Table 2:

Univariate analysis of variables comparing recipients with and without incident PVT at the time of liver transplantation

Incident PVT (n=4,311) No Incident PVT (n=62,254) p-value
African American, n (%) 260 (6.3) 5856 (9.4) <0.001
Age, years, mean (95% CI) 55.3 (55.0–55.6) 54.0 (53.9–54.1) <0.001
Diabetes, n (%) 1360 (31.5) 15476 (24.9) <0.001
HCC, n (%) 958 (22.2) 14934 (24.0) 0.01
HCV, n (%) 1066 (24.7) 18212 (29.3) <0.001
Hispanic, n (%) 671 (15.6) 8014 (12.9) <0.001
MELD, mean (95% CI) 17.3 (17.1–17.6) 18.1 (18.0–18.2) <0.001
Moderate-severe ascites, n (%) 1427 (33.1) 18010 (28.9) <0.001
NASH, n (%) 751 (17.4) 7693 (12.4) <0.001
TIPS, n (%) 587 (13.6) 6253 (10.0) <0.001

Hepatitis C; MELD=Model for End Stage Liver Disease; NASH=Nonalcoholic Steatohepatitis; PVT=Portal Vein Thrombosis; TIPS=Transjugular Intrahepatic Portosystemic Shunt

The proportion of NASH was greater among total candidates with incident PVT while HCV was less frequent. Race and ethnicity were important as well with greater rates of PVT in Hispanics and lower rates in Blacks.